Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

399

Participants

Timeline

Start Date

May 27, 2011

Primary Completion Date

November 24, 2014

Study Completion Date

November 24, 2014

Conditions
PainAdvanced Cancer
Interventions
DRUG

Nabiximols

DRUG

Placebo (GA-0034)

Trial Locations (68)

2900

Komárom

3000

Vratsa

4412

Nyíregyháza

10003

New York

10435

Berlin

10700

Mexico City

30060

Marietta

30265

Newnan

30281

Stockbridge

30625

Hanover

31238

Chihuahua City

33136

Miami

33756

Clearwater

34691

Holiday

34994

Stuart

36039

Fulda

41101

Ashland

44119

Cleveland

59802

Missoula

60031

Gurnee

60311

Frankfurt

62864

Mount Vernon

64710

Monterrey

65189

Wiesbaden

71105

Shreveport

71111

Bossier City

91204

Glendale

95403

Santa Rosa

130095

Târgovişte

400015

Cluj-Napoca

430031

Baia Mare

500366

Brasov

550245

Sibiu

620165

Focşani

700503

Iași

720237

Suceava

810325

Brăila

900591

Constanța

08009

Berlin

10010-4086

New York

98503-1010

Lacey

256 01

Benešov

370 01

České Budějovice

370 87

České Budějovice

466 01

Jablonec nad Nisou

304 60

Pilsen

356 01

Sokolov

415 01

Teplice

07747

Jena

85-796

Bydgoszcz

42-200

Częstochowa

42-217

Częstochowa

13-200

Działdowo

80-208

Gdansk

57-300

Kłodzko

27-400

Ostrowiec Świętokrzyski

61-245

Poznan

02-781

Warsaw

00717

Ponce

011461

Bucharest

GL53 0QJ

Cheltenham

M20 4BX

Withington

NR31 6LA

Great Yarmouth

CV2 2HJ

Coventry

G12 0YN

Glasgow

M8 5RB

Manchester

NR4 7UY

Norwich

PL6 8DH

Plymouth

Sponsors
All Listed Sponsors
collaborator

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

lead

Jazz Pharmaceuticals

INDUSTRY